Dianhydrogalactitol
Showing 1 - 6 of 6
Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Guangzhou (VAL-083 (Dianhydrogalactitol))
Active, not recruiting
- Glioma
- +4 more
- VAL-083 (Dianhydrogalactitol)
-
Guangzhou, ChinaSun Yat-Sen University Cancer Center
Mar 23, 2022
Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)
Active, not recruiting
- Glioma
- +4 more
- VAL-083, Dianhydrogalactitol
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 23, 2022
Ovarian Cancer Trial in Phoenix, Detroit, Nashville (VAL-083, Dianhydrogalactitol)
Withdrawn
- Ovarian Cancer
- VAL-083, Dianhydrogalactitol
-
Phoenix, Arizona
- +2 more
Oct 16, 2019
Glioblastoma Multiforme, Glioblastoma, Glioma Trial in United States (VAL-083, Dianhydrogalactitol, Physician's Choice of
Terminated
- Glioblastoma Multiforme
- +4 more
- VAL-083, Dianhydrogalactitol
- +3 more
-
Los Angeles, California
- +4 more
Nov 12, 2019
Glioma, Glioblastoma, Glioblastoma Multiforme Trial in United States (VAL-083 (Dianhydrogalactitol))
Completed
- Glioma
- +4 more
- VAL-083 (Dianhydrogalactitol)
-
San Francisco, California
- +4 more
Jan 19, 2017